ResearcherGarvan Institute of Medical ResearchActive in the last 2 years

Ellie T. Y. Mok

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-7750-3335; OpenAlex author ID A5014469661. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

miRNAs in pancreatic cancer progression and metastasis. Co-author DOI 10.1007/s10585-023-10256-0 ↗
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Co-author DOI 10.1038/s43018-023-00614-y ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Thomas R. Cox · 1 shared paper, 2024 · strength 0.36
- Paper miRNAs in pancreatic cancer progression and metastasis. DOI 10.1007/s10585-023-10256-0 ↗
Jessica L. Chitty · 1 shared paper, 2024 · strength 0.36
- Paper miRNAs in pancreatic cancer progression and metastasis. DOI 10.1007/s10585-023-10256-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.